No Added Benefit From Revascularization in Low-Risk CAS ...Middle East

Medscape - News
Optimized medical therapy may be enough in patients with carotid artery stenosis who have a low to intermediate stroke risk, after the ESCT-2 trial showed no benefit from adding revascularization. Medscape Medical News

Hence then, the article about no added benefit from revascularization in low risk cas was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( No Added Benefit From Revascularization in Low-Risk CAS )

Apple Storegoogle play

Last updated :

Also on site :